Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Largest number of CUADS graduates at UFS
2017-07-03

Description: Largest number of CUADS graduates 2017 Tags: Largest number of CUADS graduates 2017

During the mid-year graduation ceremonies at the
University of the Free State (UFS), the Centre for
Universal Access and Disability Support (CUADS) saw
the largest number of students with disabilities graduating.
Photo: Johan Roux

During the mid-year graduation ceremonies at the University of the Free State (UFS), the Centre for Universal Access and Disability Support (CUADS) saw the largest number of students with disabilities graduating.

For the first time since being established in February 2001, a total number of 30 students graduated, of which seven were postgraduate students.

Accomplishing your dreams as a student
Martie Miranda, Head of CUADS, says that one cannot help but become emotional with joy and happiness. “The feeling of satisfaction we feel with the graduates is so valuable, because it’s a reminder of their abilities to accomplish their dreams just like any other student.”

CUADS aims to ensure that the UFS creates opportunities for students with disabilities, aiming to become a higher-education institution recognised for its efforts in human reconciliation. Together with the Exam Division, CUADS coordinates alternative assessment with an accessible test and examination facility housed at CUADS. This accommodates students with concessions, amanuensis, specialised equipment, and accessible formatted papers.

Changing the challenges you experience
Miranda continuously encourages students to keep going. “If being successful is important to you, you will find a way to change the challenges you experience into opportunities. Either to learn something about yourself or teach someone else something.”

Below are the number of graduates from each faculty:
•    Faculty of Law: 2
•    Faculty of Economics and Management Sciences: 4
•    Faculty of Education: 4
•    Faculty of Natural and Agricultural Science: 9
•    Faculty of the Humanities: 11

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept